We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTG
5326
DELISTED
Tortoise Midstream Energy Fund, Inc. Common Stock
NTG
$2K ﹤0.01%
52
-592
-92% -$16.9K
TTOO
5327
DELISTED
T2 Biosystems, Inc
TTOO
-1
Closed -$5.03K
RMGC
5328
DELISTED
RMG Acquisition Corp. III Class A Ordinary Shares
RMGC
$2K ﹤0.01%
+177
New +$1.72K
MOTS
5329
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$2K ﹤0.01%
+10
New +$2.52K
ALTU
5330
DELISTED
Altitude Acquisition Corp
ALTU
$2K ﹤0.01%
248
-685
-73% -$6.72K
PHXM
5331
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$2K ﹤0.01%
+30
New +$1.68K
CTG
5332
DELISTED
Computer Task Group, Inc.
CTG
$2K ﹤0.01%
+237
New +$2.08K
CCVI
5333
DELISTED
Churchill Capital Corp VI
CCVI
$2K ﹤0.01%
+236
New +$2.32K
USDP
5334
DELISTED
USD PARTNERS LP
USDP
$2K ﹤0.01%
+292
New +$1.95K
HLGN
5335
DELISTED
Heliogen, Inc.
HLGN
$2K ﹤0.01%
+7
New +$2.42K
DKDCU
5336
DELISTED
Data Knights Acquisition Corp. Unit
DKDCU
$2K ﹤0.01%
150
+100
+200% +$1.04K
AAC.U
5337
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
$2K ﹤0.01%
226
+126
+126% +$1.25K
CYTO
5338
DELISTED
Altamira Therapeutics Ltd
CYTO
$2K ﹤0.01%
+2
New +$2.25K
CCV.U
5339
DELISTED
Churchill Capital Corp V Units, each consisting of one share of Class A common stock, and one-fourth of one redeemable warrant
CCV.U
$2K ﹤0.01%
162
-108
-40% -$1.1K
CCAIU
5340
DELISTED
Cascadia Acquisition Corp. Unit
CCAIU
$2K ﹤0.01%
+234
New +$2.31K
APGN
5341
DELISTED
Apexigen, Inc. Common Stock
APGN
$2K ﹤0.01%
172
+118
+219% +$1.17K
YVR
5342
DELISTED
Liquid Media Group Ltd. Common Shares
YVR
$2K ﹤0.01%
+373
New +$2.6K
MTACU
5343
DELISTED
MedTech Acquisition Corporation Unit
MTACU
$2K ﹤0.01%
215
+115
+115% +$1.16K
CLBR.U
5344
DELISTED
Colombier Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant
CLBR.U
$2K ﹤0.01%
+176
New +$1.74K
FMIVU
5345
DELISTED
Forum Merger IV Corporation Unit
FMIVU
$2K ﹤0.01%
174
+4
+2% +$40
IMBI
5346
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$2K ﹤0.01%
383
-35
-8% -$225
LITTU
5347
DELISTED
Logistics Innovation Technologies Corp. Units
LITTU
$2K ﹤0.01%
+206
New +$2.05K
SNRHU
5348
DELISTED
Senior Connect Acquisition Corp. I Unit
SNRHU
$2K ﹤0.01%
180
+97
+117% +$975
TRKA
5349
DELISTED
Troika Media Group, Inc. Common Stock
TRKA
$2K ﹤0.01%
+69
New +$3.25K
CIIGU
5350
DELISTED
CIIG Capital Partners II, Inc. Unit
CIIGU
$2K ﹤0.01%
+245
New +$2.47K

Similar funds

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.